With the rise in the popularity of weight loss drugs like ‘Wegovy’ and ‘Ozempic,’ we’re learning a counterfeit market has ...

Fact checked by Nick Blackmer A recent study found that semaglutide, a GLP-1 weight loss drug, reduced knee pain in people with obesity and knee osteoarthritis.Experts say the reduced knee pain ...

In one hand, a slender young woman holds up a bottle of clear liquid. The words “Skinny” and “GLP-1” — a new class of weight loss drugs — are visible on the label. In the other hand, she raises up a ...

It was only in August when 58-year-old nurse Susan McGowan took two low-dose injections of the NHS-approved weight loss drug Tirzepatide. However, just 2 weeks into administering them, Susan ...

The weight-loss drug Ozempic can help reduce stroke patients' risk of a heart attack or death, a new study says.

Maryland’s policymakers should expand Medicaid coverage to include weight loss medications, writes Michelle Rogers.

A study reveals racial and ethnic disparities in access to Novo Nordisk's diabetes and weight loss drugs among U.S. military veterans. Black, Asian, and Native American patients are less likely to ...

The "Today" host underwent gastric bypass surgery in 2002 to help him lose weight.

Conditions are getting a bit more challenging for the drugmaker.

In good news for those averse to injections, GLP-1 agonist medication is a step closer to being offered in oral pill form, ...

Eli Lilly (NYSE: LLY) and Novo Nordisk (NYSE: NVO), the kings of the titanic weight-loss drugs market, might have a problem on their hands. After reporting their third-quarter earnings, shares of both ...

Viking aims to compete against market giants Eli Lilly and Novo Nordisk in the billion-dollar weight loss drug market. The ...